masoprocol has been researched along with Cardiovascular Stroke in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alatrag, F; Amoni, M; Gwanyanya, A; Kelly-Laubscher, R | 1 |
| Andreasen, TV; Bugge, E; Starkopf, J; Ytrehus, K | 1 |
2 other study(ies) available for masoprocol and Cardiovascular Stroke
| Article | Year |
|---|---|
Cardioprotective effect of fingolimod against calcium paradox-induced myocardial injury in the isolated rat heart.
Topics: Animals; Calcium; Cardiotonic Agents; Fingolimod Hydrochloride; In Vitro Techniques; Magnesium; Male; Masoprocol; Myocardial Infarction; Rats, Wistar; TRPM Cation Channels | 2022 |
Lipid peroxidation, arachidonic acid and products of the lipoxygenase pathway in ischaemic preconditioning of rat heart.
Topics: Analysis of Variance; Animals; Arachidonic Acid; Docosahexaenoic Acids; Fatty Acids, Nonesterified; Fatty Acids, Unsaturated; Ischemic Preconditioning, Myocardial; Linoleic Acids; Lipid Peroxidation; Lipoxygenase; Lipoxygenase Inhibitors; Male; Masoprocol; Myocardial Infarction; Myocardial Ischemia; Myocardium; Perfusion; Phospholipids; Rats; Rats, Wistar | 1998 |